In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Noxxon Pharma AG

www.noxxon.com

Latest From Noxxon Pharma AG

BIO-Europe 2018: EU Biotechs Can Create More Value With US Presence

Europe's biotech companies can add value by taking a global view, Scrip heard at Bio-Europe.

Europe Business Strategies

Pipeline Watch: Phase III Starts With Fitusiran In Hemophilia, Zoliflodacin In Gonorrhea, Opdivo Combo In RCC

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Battle Lines Drawn In New Renal Anemia Market

The treatment landscape in renal anemia is set for major changes over the next few years as a novel class of drugs approaches the market. A new report from Biomedtracker looks at the major players battling it out in the clinic.

Research & Development Blood & Coagulation Disorders

Noxxon CEO Talks Partnering Strategy & Cancer Combos

Aram Mangasarian, CEO of Noxxon Pharma, a biotech company focused on cancer therapies targeting the tumor microenvironment, discusses partnering options and his strategy for how Noxxon can compete in the busy immuno-oncology space.

StartUps and SMEs Cancer
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Noxxon Pharma AG
  • Senior Management
  • Aram Mangasarian, PhD, CEO
    Matthias Baumann, MD, CMO
  • Contact Info
  • Noxxon Pharma AG
    Phone: (49) 30 726247 0
    Max-Dohrn-Str. 8-10
    10589
    Berlin,
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register